There are currently 1 ongoing clinical trials involving Creutzfeldt Jakob Disease
Of the 1 trials,1 trials are in Phase I
Furthermore, 1 trials are in Phase I
The global pharmaceutical industry is steadily developing new drugs for Creutzfeldt Jakob Disease, a central nervous system condition.
University College London Hospitals NHS Foundation Trust: The leading ongoing Creutzfeldt Jakob Disease related clinical trial sponsor
University College London Hospitals NHS Foundation Trust is among the notable clinical trial sponsors involved in Creutzfeldt Jakob Disease. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
United States of America
United States of America
United States of America
United States of America
France
United States of America
United States of America
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer